Showing results (651-660 of 671) with videos related to
Sort By:
Pageof 68
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.Cell Reports. Medicine|July 14, 2026
Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancersMeijie Tian, Katrina Jia, Jerry T Wu, et al.Nature Communications|December 16, 2014
Time-resolved compression of a capsule with a cone to high density for fast-ignition laser fusionW Theobald, A A Solodov, C Stoeckl, et al.Cell Reports. Medicine|June 3, 2020
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung CancerNitin Roper, Anna-Leigh Brown, Jun S Wei, et al.The Review of Scientific Instruments|December 3, 2008
Diagnostics for fast ignition science (invited)A G MacPhee, K U Akli, F N Beg, et al.Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.Nature|November 13, 2015
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphismDerek A Oldridge, Andrew C Wood, Nina Weichert-Leahey, et al.Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Germline pathogenic variants in 786 neuroblastoma patientsJung Kim, Zalman Vaksman, Laura E Egolf, et al.Physical Review Letters|April 7, 2010
Limitation on prepulse level for cone-guided fast-ignition inertial confinement fusionA G Macphee, L Divol, A J Kemp, et al.Blood Cancer Journal|March 14, 2015
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromesK L McGraw, L M Zhang, D E Rollison, et al.Pageof 68